Treatment(s) already received-None - Page 12 of 14 Posts on Medivizor
Navigation Menu

Treatment(s) already received-None Posts on Medivizor

Personalized Tamoxifen Treatments

Personalized Tamoxifen Treatments

Posted by on Mar 4, 2013 in Breast cancer | 0 comments

Most patients on Tamoxifen receive a standard dose of medication. However, patients may benefit more from individually adjusted doses. This paper highlights potential strategies for personalized Tamoxifen treatments. Tamoxifen is not active on its own. Once ingested, the body converts it into other substances (metabolites). Some of these...

Read More

The impact of radiotherapy protocol on quality of life in patients with operable rectal cancer

The impact of radiotherapy protocol on quality of life in patients with operable rectal cancer

Posted by on Mar 3, 2013 in Colorectal cancer | 0 comments

In a nutshell This article evaluated the long-term quality of life of patients with rectal cancer, treated with either a short course of radiation before surgery, or postoperative chemo-radiation. Patients treated with pre-operative radiation reported worse sexual- and bowel-related functional outcomes.   Some background In patients with...

Read More

Recurrence rate after surgical prostate removal in men older than 70 years of age

Posted by on Feb 26, 2013 in Prostate cancer | 0 comments

Due to the increase in life expectancy, there exists an increasing number of patients with prostate cancer (PCA) in many populations. However, there is no consensus on screening and treatment of PCA in the medical fraternity. This paper investigated the oncological outcomes of radical prostatectomy (RP) in older men (> 70) compared to RP outcomes in...

Read More

Evaluating quality of life and adverse effects of proton therapy in young men with prostate cancer

Evaluating quality of life and adverse effects of proton therapy in young men with prostate cancer

Posted by on Feb 26, 2013 in Prostate cancer | 0 comments

The present study evaluated the quality of life and adverse effects for patients younger than 60 with prostate cancer following proton therapy. The main findings were that young prostate cancer patients treated with proton therapy have great outcomes with respect to urinary and sexual function. The prostate is a small gland only found in men that has...

Read More

Treating tumors of the appendix to reduce the risk of spread to the abdominal cavity

Posted by on Feb 26, 2013 in Colorectal cancer | 1 comment

In a nutshell The present study classified tumors of the appendix and reviewed treatments that aim to prevent cancer spread to the abdominal cavity. Some background Pseudomyxoma peritonei (PMP) is a rare condition caused by the production of too much mucin (a protein that is secreted in mucus).  PMP affects women more than men and symptoms...

Read More

Rising PSA levels after radiation treatment can predict prostate cancer mortality

Rising PSA levels after radiation treatment can predict prostate cancer mortality

Posted by on Feb 25, 2013 in Prostate cancer | 0 comments

In a nutshell This article evaluated whether the interval to biochemical failure (IBF) can be used as a prediction factor for prostate cancer mortality. The IBF was found to be the best current predictor of prostate cancer mortality in patients previously treated with radiation therapy. Some background Biochemical failure is defined...

Read More

Cancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science

Cancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science

Posted by on Feb 25, 2013 in Breast cancer | 0 comments

This article summarizes recent findings regarding cognitive problems and decline in patients previously treated with chemotherapy.  It gives a comprehensive overview of results from neuropsychological, imaging and animal studies. It also proposes investigating post-chemotherapy mental decline in the context of the normal aging process. In long...

Read More

Combining Bevacizumab with chemotherapy for advanced colorectal cancer: efficacy evaluation

Combining Bevacizumab with chemotherapy for advanced colorectal cancer: efficacy evaluation

Posted by on Feb 25, 2013 in Colorectal cancer | 0 comments

In a nutshell The present study evaluated whether combining Bevacizumab (Avastin) with chemotherapy for patients with stage IV (metastatic) colorectal cancer (CRC) has any benefits in the terms of survival and quality of life. Main findings: Bevacizumab may be beneficial only as part of certain chemotherapy regimens. Some...

Read More

Postoperative radiotherapy prevents breast cancer recurrence and prolongs survival

Posted by on Feb 25, 2013 in Breast cancer | 0 comments

In a nutshell This study evaluated if strategies to prevent cancer recurrence are associated with prolonged survival 15 years after treatment. Their main findings were that postoperative radiation managed to prevent cancer recurrence and was associated with higher rates of long-term survival. Some background Early breast cancer is often treated...

Read More